Article
Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling.
Oncogene - 28 Apr 2016
Kruiswijk F, Hasenfuss S C, Sivapatham R, Baar M P, Putavet D, Naipal K A T, van den Broek N J F, Kruit W, van der Spek P J, van Gent D C, Brenkman A B, Campisi J, Burgering B M T, Hoeijmakers J H J, de Keizer P L J
Abstract excerpt
Melanoma is the most lethal form of skin cancer and successful treatment of metastatic melanoma remains challenging. BRAF/MEK inhibitors only show a temporary benefit due to rapid occurrence of resistance, whereas immunotherapy is mainly effective in selected subsets of patients. Thus, there is a need to identify new targets to improve treatment of metastatic melanoma. To this extent, we searched for markers that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
